Advertisements



We are Sorry, This Page doesn't Exist


Pluristem shares jump 2% on news of positive trial of treatment for radiation damage

Pluristem Therapeutics Inc.....»»

Category: topSource: marketwatchJun 25th, 2018

Cara Therapeutics Shares Jump On Licensing Deal For Pruritis Treatment

Shares of Cara Therapeutics Inc (NASDAQ: CARA) are surging to a three-month high in reaction to a licensing agreement the biotech company announced with Vifor Fresenius Medical Care Renal Pharma. read more.....»»

Category: blogSource: benzingaMay 23rd, 2018

Citi upgrades Spark Therapeutics to Buy with shares down nearly 30%

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Why Spark"s stock price is down 30 percent

Despite posting its first-ever profitable quarter, shares of Spark Therapeutics were trading down 30 percent Tuesday morning after the Philadelphia gene therapy company reported two patients had an adverse immune response to its experimental hemophilia.....»»

Category: topSource: bizjournalsAug 7th, 2018

Ovid Therapeutics shares fall 28% as investors question new drug data (OVID)

Markets Insider New York-based biotech company Ovid Therapeutics announced on Monday positive phase 2 trial results for its treatment for a rare disease called Angelman Syndrom.....»»

Category: topSource: businessinsiderAug 6th, 2018

Insys shares slide 7.6% after FDA rejects its spray treatment for pain

Shares of biotech Insys Therapeutics Inc. slid 7.6% Friday, after the company said the U.S. Food and Drug Administration has declined to a.....»»

Category: topSource: marketwatchJul 27th, 2018

Aquestive Therapeutics shares jump 5.7% in trading debut

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJul 25th, 2018

Compugen shares jump as FDA lifts clinical hold on cancer treatment application

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 2nd, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Pain, Durect Plunge as FDA Committee Votes Against Remoxy ER

Pain Therapeutics (PTIE) plunges as the FDA Advisory Committee votes against the approval of its lead candidate, Remoxy ER. Shares of Pain Therapeutics, Inc. PTIE an.....»»

Category: worldSource: nytJun 28th, 2018

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

UPDATE: Summit Therapeutics shares plummet 77% after trial of DMD treatment fails to meet main goals

Summit Therapeutics plc shares plunged 77% in premarket trade Wednesday, after.....»»

Category: topSource: marketwatchJun 27th, 2018

Global Blood Therapeutics shares drop after late-stage data for sickle cell disease treatment

Global Blood Therapeutics Inc. shares dropped as much as 12% in premarket trade on Wednesday after the company reported results for a late-stage trial of sickle cell disease therapy, and said that it met with the U.S. Food and Drug Ad.....»»

Category: topSource: marketwatchJun 27th, 2018

Heron Therapeutics stock rockets 30% on high hopes for post-surgery pain treatment

Heron Therapeutics Inc. shares surged 33.6% Thursday, after the company announced positive developments for its treatments for postoperative pain that aim to reduce patient dependence on opioids. A competitor’s stock slumped......»»

Category: topSource: marketwatchJun 21st, 2018

Heron Therapeutics stock rockets 31% on high hopes for post-surgery pain treatment

Heron Therapeutics Inc. shares surged 33.6% Thursday, after the company announced positive developments for its treatments for postoperative pain that aim to reduce patient dependence on opioids. A competitor’s stock slumped......»»

Category: topSource: marketwatchJun 21st, 2018

Heron Therapeutics shares surge 33% after positive FDA response to pain treatment

Heron Therapeutics Inc. shares surged 33.6% in premarket trade Thursday, after the company annou.....»»

Category: topSource: marketwatchJun 21st, 2018

Maxim Explains Viking Therapeutics" Sympathy Move With Madrigal

Viking Therapeutics Inc (NASDAQ: VKTX) shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Latest R.....»»

Category: blogSource: benzingaJun 2nd, 2018

Why Cara Therapeutics Shares Are Soaring

Cara Therapeutics shares made a solid gain on Wednesday after the firm announced that it has licensed rights to commercialize Korsuva injection for the treatment of chronic kidney disease-associated........»»

Category: blogSource: 247wallstMay 23rd, 2018

Menlo Therapeutics" stock plunges over 50% after disappointing trial results

Shares of Menlo Therapeutics Inc. lost more than half their value in premarket trade Monday, after the biopharmaceutical company's skin condition treatment failed to meet its primary or key secondary efficacy endpoints. The phase 2 trial showed no stat.....»»

Category: topSource: marketwatchApr 9th, 2018

Ionic Pharmaceuticals shares jump 3% premarket on news of license deal with AstraZeneca

Ionis Pharmaceuticals Inc. shares rose 3% premarket Monday, after the company unveiled a licensing deal with AstraZeneca PlC for a treatment for nonalcoholic steatohepatitis (NASH), or fatty liver. Ionis said it will receive .....»»

Category: topSource: marketwatchApr 9th, 2018